![]() |
市场调查报告书
商品编码
1895969
人工智慧(AI)市场规模、份额及成长分析(按组件、应用、技术、最终用户和地区划分)-医疗保健产业预测(2026-2033年)Artificial Intelligence (AI) in Healthcare Market Size, Share, and Growth Analysis, By Component (Hardware, Services), By Application (Robot Assisted Surgery, Virtual Assistants), By Technology, By End User, By Region-Industry Forecast 2026-2033 |
||||||
预计到 2024 年,全球医疗保健领域的人工智慧 (AI) 市场规模将达到 274.6 亿美元,到 2025 年将成长至 377 亿美元,到 2033 年将成长至 4761.4 亿美元,在预测期(2026-2033 年将成长至 4761.4 亿美元,在预测期(2026-2033 年)内复合年增长率为 37.3%。
受对提升患者照护、提高营运效率和降低成本的需求不断增长的推动,医疗保健领域的人工智慧(AI)市场正经历强劲成长。医疗保健数据的快速增长、计算能力的提升以及向价值医疗模式的转变,正推动人工智慧在包括诊断成像、临床决策支援、药物研发和病患监测在内的各种应用中得到广泛应用。人工智慧能够快速分析大量数据,从而实现疾病的早期发现、个人化治疗和更有效率的管理流程。然而,资料隐私、互通性问题和伦理考量等挑战仍然是人工智慧广泛应用的障碍。公共和私营部门的持续投资、技术进步和监管改革有望解决这些挑战,并释放人工智慧的潜力,从而改变全球医疗保健服务。
全球医疗保健人工智慧 (AI) 市场驱动因素
医疗保健数据的快速增长(预计将超过10Zetta位元组)正在推动对超越传统方法的AI分析的需求。来自电子健康记录、医学影像、基因组学、穿戴式装置和真实世界数据的复杂数据需要先进的分析工具。人工智慧能够加快诊断速度、增强预测风险评分并实现个人化治疗决策,例如梅奥诊所与Google健康合作,从而促进疾病的早期发现。透过利用预测分析,人工智慧有望显着降低医院再入院率,使不断增长的数位健康用户群受益。此外,人工智慧还能提高营运效率,缩短从咨询到计费的过渡时间。最终,它将医疗保健数据转化为可执行的洞察,从而有助于改善患者预后和优化营运流程。
全球医疗保健人工智慧 (AI) 市场面临的限制因素
全球医疗保健领域的人工智慧 (AI) 市场面临着许多挑战,主要集中在资料隐私和安全方面。人工智慧技术需要大量的患者健康信息,这使得医疗保健行业更容易遭受网路攻击,并增加了资料外洩和勒索软体攻击的风险。遵守 HIPAA 和 GDPR 等严格的法规结构进一步加剧了这个问题,因为这些框架的要求复杂,且资料匿名化技术本身也存在潜在风险,可能导致病患身分被重新识别。此外,患者群体普遍缺乏信任也阻碍了资料共用,许多人由于担心资讯被滥用而不愿提供个人资讯。未来发展需要采用强大的加密技术、区块链解决方案、联邦学习以及清晰的管治结构来建立伦理准则。人工智慧隐私是未来医疗保健领域创新的基本要求。
全球人工智慧(AI)市场在医疗领域的趋势
随着医疗服务提供者加速在包括放射科和病理科在内的各个专科领域采用人工智慧(AI)驱动的诊断工具,全球医疗保健领域的人工智慧市场呈现显着上升趋势。对高效、精准诊断的日益重视以及对及时医疗服务持续不断的压力,正推动着对旨在早期疾病检测和改进临床决策的人工智慧解决方案的投资。从敏捷的Start-Ups到老字型大小企业,随着市场参与者加速创新,将人工智慧技术融入患者照护的核心,有望重塑医疗服务模式,最大限度地减少诊断错误,并最终改善全球患者的治疗效果。
Global Artificial Intelligence (AI) in Healthcare Market size was valued at USD 27.46 Billion in 2024 and is poised to grow from USD 37.7 Billion in 2025 to USD 476.14 Billion by 2033, growing at a CAGR of 37.3% during the forecast period (2026-2033).
The market for Artificial Intelligence (AI) in healthcare is experiencing robust growth driven by the increasing demand for enhanced patient care, operational efficiency, and cost savings. The surge in healthcare data and advancements in computing power, coupled with a shift toward value-based care, have amplified the utilization of AI across various applications, including diagnostic imaging, clinical decision support, drug discovery, and patient monitoring. AI's ability to swiftly analyze large datasets allows for early disease detection, personalized treatments, and improved administrative efficiency. However, challenges such as data privacy, interoperability issues, and ethical concerns pose obstacles to widespread adoption. Ongoing investments from public and private sectors, alongside evolving technologies and regulatory reforms, may address these challenges and unlock AI's potential to transform healthcare delivery globally.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Intelligence (AI) in Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Artificial Intelligence (AI) in Healthcare Market Segments Analysis
Global Artificial Intelligence (AI) in Healthcare Market is segmented by Component, Function, Deployment Model, Technology, End User, Application and region. Based on Component, the market is segmented into Hardware, Software Solutions and Services. Based on Function, the market is segmented into Diagnosis & Early Detection, Treatment Planning & Personalization, Patient Engagement & Remote Monitoring, Post-Treatment Surveillance & Survivorship Care, Pharmacy Management, Data Management & Analytics and Administrative. Based on Deployment Model, the market is segmented into On-Premises Model, Cloud Based Model and Hybrid Model. Based on Technology, the market is segmented into Machine Learning, Natural Language Processing (NlP), Context-Aware Computing, Generative Ai, Pattern & Image Recognition, Computer Vision and Image Analysis. Based on End User, the market is segmented into Healthcare Providers, Healthcare Payers, Patients and Others. Based on Application, the market is segmented into Robot-assisted Surgery, Virtual Assistants, Administrative Workflow Assistants, Connected Medical Devices, Medical Imaging & Diagnostics, Clinical Trials,Fraud Detection, Cybersecurity, Dosage Error Reduction, Precision Medicine, Drug Discovery & Development, Lifestyle Management & Remote Patient Monitoring, Wearables and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Artificial Intelligence (AI) in Healthcare Market
The burgeoning volume of healthcare data, projected to reach over 10 zettabytes, is driving the demand for AI-enabled analytics that surpass traditional methods. The complexity of data derived from electronic health records, medical imaging, genomics, wearables, and real-world evidence necessitates advanced analytical tools. AI enhances diagnostic speed, boosts predictive risk scoring, and personalizes treatment decisions, exemplified by partnerships such as Mayo Clinic and Google Health, improving early disease detection. By leveraging predictive analytics, AI has significantly reduced hospital readmissions and is set to benefit an expanding digital health user base. Additionally, AI streamlines operational efficiency, cutting the transition time from care to billing, ultimately converting healthcare data into actionable insights that enhance patient outcomes and operational workflows.
Restraints in the Global Artificial Intelligence (AI) in Healthcare Market
The Global Artificial Intelligence (AI) in Healthcare market faces considerable obstacles primarily related to data privacy and security. As AI technologies require extensive patient health information, the healthcare sector becomes increasingly vulnerable to cyberattacks, resulting in heightened risks such as data breaches and ransomware incidents. Compliance with stringent regulatory frameworks, such as HIPAA and GDPR, complicates the landscape due to complex requirements, along with potential risks associated with data anonymization techniques that may lead to re-identification. Additionally, a pervasive lack of trust within the patient community hinders data sharing, as many individuals hesitate to contribute their information out of concern for misuse. The path forward necessitates the implementation of robust encryption, blockchain solutions, federated learning, and well-defined governance structures to establish ethical guidelines, making AI privacy a fundamental requirement for future innovation in healthcare.
Market Trends of the Global Artificial Intelligence (AI) in Healthcare Market
The Global Artificial Intelligence (AI) in Healthcare market is experiencing a significant upward trend as healthcare providers increasingly adopt AI-powered diagnostic tools across various specialties, notably in radiology and pathology. The heightened focus on delivering efficient and accurate diagnostics, compounded by ongoing pressures for timely healthcare delivery, is propelling investments in AI-driven solutions aimed at enhancing early disease detection and clinical decision-making. As market players, ranging from agile startups to established corporations, accelerate innovation, the integration of AI technologies at the forefront of patient care is set to reshape healthcare delivery, minimize diagnostic errors, and ultimately improve patient outcomes on a global scale.